Fossil Remedies

JANUARY 19, 2022

Experts say that one should choose an ISO-certified company that works as per the standards and guidelines laid by WHO and GMP. The company should have a countrywide distribution network and a customer-oriented approach. The PCD pharma company you choose should have a good reputation and bright history.

Production 98

Production Pharma Companies Pharma Production Marketing 98

pharmaphorum

APRIL 19, 2022

RudaCure is a four-year-old biotech company based in the South Korea, focusing on ocular disease and chronic pain with a pair of potentially first-in-class drugs. The company recently raised $16.5 So] we are trying to go for the international market.”. “In The company’s second drug candidate, RCI002, is focused on chronic pain.

Marketing 52

Marketing Clinical Trials Clinical Trials Development 52

Delveinsight

AUGUST 23, 2021

The present treatment approach in the Von Hippel-Lindau therapy market revolves around controlling and preservation of functional parenchyma to avoid the morbidity associated with renal or adrenal loss. by 2030 Owing to Increasing Prevalence and Emerging Therapieswth of the VHL disease pipeline market and influx of key pharma companies.

Marketing 98

Marketing Clinical Trials Clinical Trials Trials 98

Pharmaceutical Technology

SEPTEMBER 2, 2022

In a recent report, GlobalData revealed that the US Food and Drug Administration (FDA) approved 122 new drug applications (NDAs) and biologic license applications (BLAs) in 2021. This is where partners such as Abacus Medicine Pharma Services can really help,” says Simon Estcourt, managing director of Abacus Medicine Pharma Services.

Drugs 130

Drugs Pharma Companies Medicine Production 130

Pharmaceutical Technology

APRIL 17, 2023

Telix has announced the successful preclinical development of radiolabelled olaratumab, an antibody licensed by Eli Lilly and Company. But, following negative Phase III efficacy results, Lilly withdrew the drug from the market. After this, Telix licenced the drug for $5m.

Development 130

Development Antibody Pharma Companies Licensing 130

pharmaphorum

DECEMBER 7, 2020

Bureaucracy, political upheaval, and lack of regulations continue to make Latin America a difficult market for European and North American pharma to enter – and COVID-19 has only worsened these issues. Developing market specialist Dr Zulf Masters OBE takes us through the nuances of being successful in this region.

Marketing 92

Marketing Regulation Production Medicine 92

pharmaphorum

MAY 17, 2021

UK biotech Arecor Therapeutics has announced plans to float on the London stock market, to fund plans to develop novel formulations of insulins and other biological drugs with enhanced properties. Arecor has four active licensing agreement in place with partners including Hikma and Inhibrx.

Insulin 52

Insulin Production Marketing Pharma Companies 52

pharmaphorum

AUGUST 25, 2021

Jirair Ratevosian, executive director of global patient solutions and government affairs at Gilead Sciences, tells us how his company utilised previously developed partnerships and their knowledge of providing global access to HIV treatments to distribute Remdesivir. We went back to what we do best … we engaged our network of companies.

Marketing 52

Marketing Licensing Licensing Manufacturing 52

Pharmaceutical Technology

AUGUST 1, 2022

As a result, multiple vaccines, including Pfizer /BioNTech’s mRNA vaccine, Comirnaty, were licensed for use within a year of development beginning. Many new therapeutics are needed to treat the broad range of bacterial infections, and bringing new antibiotics to market is both difficult and expensive.

Vaccine 234

Vaccine Vaccination Bacteria Life Science 234

XTalks

MAY 29, 2024

The global pharmaceutical market has been expanding at an unprecedented pace. According to Statista , in 2023, the market was estimated to be worth about $1.6 The top ten pharma companies in 2023 by revenue accounted for about 35 percent of the market value, with total earnings of $559.5 billion last year, up 4.2

Pharma Companies 52

Pharma Companies Sales FDA Approval Vaccine 52

World of DTC Marketing

APRIL 12, 2021

QUICK READ: Pharma supply chain issues are a concern for us all but especially patients. The goal of getting a drug to market as fast as possible so they can recoup drug development costs has the potential for mistakes that could cost lives. Why would a pharma company take risks like these? Patients should be scared.

Generic Drugs 187

Generic Drugs Manufacturing Drugs Production 187

Pharmaceutical Technology

MARCH 31, 2023

On March 30, ViiV Healthcare and Medicines Patent Pool (MPP), announced sublicensing agreements with the pharma manufacturers Aurobindo , Cipla and Viatris to produce generic forms of the long-acting cabotegravir used as pre-exposure prophylaxis (PrEP) for HIV. GSK owns a majority stake in ViiV Healthcare.

Medicine 130

Medicine Manufacturing Pharma Companies Licensing 130

Fossil Remedies

AUGUST 21, 2019

A pharma franchise business model is when a company permits to sell the products by its name. It is an agreement between a franchiser which is typically a pharma manufacturing (or marketing) company where a franchisee is an individual entrepreneur or a small company that buys the license.

Pharma Companies 40

Pharma Companies Production Licensing Licensing 40

pharmaphorum

JANUARY 8, 2021

There’s a new player in the neurology and mental health drugs market after Italy’s Angelini Pharma merged with Switzerland’s Arvelle Therapeutics in a deal worth up to $960 million based around the anti-seizure drug cenobamate. It is already in the late stages of development and expected to be approved in Europe later this year.

Licensing 52

Licensing Licensing Pharma Companies Medicine 52

pharmaphorum

JANUARY 20, 2022

The mission to treat people who suffer from allergic rhinitis has been given a boost as two pharma companies join forces. This partnership will provide patients access to a highly effective and proven treatment for allergic rhinitis in these key South-East Asian markets.”. with allergic rhinitis.

Allergies 72

Allergies Marketing Production Manufacturing 72

pharmaphorum

JULY 14, 2022

The legacy product now lies outside Bayer’s core areas of cardiology, oncology, haematology, ophthalmology, women’s health and radiopharmaceuticals, and the funds raised from the sale will support the “ongoing transformation of Bayer’s pharma business to focus on key areas of future medical innovation”, said the company.

Drugs 92

Drugs Sales Pharma Companies Cardiology 92

pharmaphorum

SEPTEMBER 20, 2021

For the pharma industry, the pandemic’s changes were both abrupt and industry-altering, requiring companies to rapidly adapt their approaches to drug development and commercialisation. It also led to changes in how we manufacturer, market and ship medications. Personalisation is Key.

Sales 97

Sales Marketing Pharma Companies Licensing 97

pharmaphorum

JUNE 14, 2021

Rebecca Sanders from Lipodystrophy UK tells us how the patient voice helped convince NICE to approve a much-needed drug for this rare disease, and explores how regulators and pharma companies can help make patient involvement in HTA more impactful. This article appears in our free digital magazine Deep Dive: Market Access 2021.

Drugs 99

Drugs Pharma Companies Licensing Licensing 99

Fossil Remedies

APRIL 26, 2022

PCD Pharma Business Plan. In a pharmaceutical business, you need a link between the pharma marketing company and the end-user, i.e., doctors, pharmacists, or others who can prescribe the medicine. This connecting link is the PCD Pharma Business. The first thing is a market research. Gather all documents.

Doctors 59

Doctors Doctor Marketing Production 59

Camargo

NOVEMBER 11, 2020

Unpacking the (Black) Box: Antares Licenses Urology Product with Boxed Warning. When the FDA requires a product’s labeling to include a boxed warning (also called a “black box warning” because the text is surrounded by black border), the potential market value of the drug often drops severely.

Development 242

Development Bioequivalency Generic Drugs Production 242

Delveinsight

AUGUST 2, 2020

The dynamics of the cancer cachexia market is expected to gain momentum as several companies are testing the waters, advancing cancer cachexia pipeline. Moreover, an increasing trend of the cancer cachexia prevalence during the forecast year is also a reason that has spurred pharma players to invest in the cancer cachexia market.

Marketing 94

Marketing Pharma Companies Development Hormones 94

pharmaphorum

FEBRUARY 12, 2021

The deal covers global rights to three brands – Zinnat (cefuroxime axetil), Zinacef (cefuroxime) and Fortum (ceftazidime) – which are sold in more than 100 markets around the world and had sales of around $140 million last year.

Drugs 111

Drugs Sales Marketing Pharma Companies 111

pharmaphorum

NOVEMBER 30, 2022

The biggest gathering of pharma companies in Europe right now on the commercial side, the Veeva Systems Summit permits the sharing of best practices and of new ideas. Facts that they gleaned included: Across Europe, only 52% of HCPs will accept a visit from a pharma company (i.e.

Life Science 98

Life Science Pharma Companies Sales Marketing 98

pharmaphorum

MARCH 8, 2022

Low-cost rivals to multiple myeloma therapy Revlimid (lenalidomide) started to become available in Europe earlier this year, and have now been introduced in the US market by Teva and Natco Pharma, under the terms of a license agreed with Revlimid’s original developer Celgene.

Sales 52

Sales Marketing Pharma Companies Licensing 52

Creogenic Pharma

FEBRUARY 17, 2021

Franchise Company. When you are attempting to find the best PCD Pharma Company, you will run into a lot of them in the country. How To Select Best PCD Pharma Franchise Company. PCD PHARMA FRANCHISE. BEST PCD PHARMA COMPANY. The post How To Select Best PCD Pharma Franchise Company?

Pharma Companies 52

Pharma Companies Production Doctors Doctor 52

pharmaphorum

JANUARY 6, 2022

The latest pharma company to make a move for an mRNA specialist is Germany’s Merck KGaA, which has offered a $780 million cash buyout to US biotech Exelead. Exelead was part of that success, helping to manufacture vaccine precursors for the Pfizer/BioNTech shot Comirnaty.

Vaccination 98

Vaccination Vaccine Manufacturing Life Science 98

pharmaphorum

MAY 20, 2022

In one of the first moves by a member of ATOM, Novartis has agreed to license rights to its tyrosine kinase inhibitor drug nilotinib – sold as Tasigna as a leukaemia treatment – to the UN-backed Medicines Patent Pool (MPP).

Drugs 111

Drugs Medicine Licensing Licensing 111

Fossil Remedies

NOVEMBER 22, 2022

If you are a budding entrepreneur who wants to launch a business of your own, then opening a pharmaceutical marketing firm could be a better choice. The pharma sector has been doing quite well for some time and the future seems to be equally exciting. Market forecasting and timely actions are the key points to success.

Pharma Production 52

Pharma Production Branding Production Marketing 52

pharmaphorum

FEBRUARY 15, 2022

billion in exercise fees and milestone payments, as well as tiered royalties should any of the ADCs reach the market. Lilly originally agreed paid $20 million upfront for a license to the maytansinoid technology in 2011, and expanded the partnership two years later, only to exit the agreement in 2018.

Antibody 52

Antibody Licensing Licensing Drugs 52

Fossil Remedies

OCTOBER 23, 2019

You can market drugs under your brand name. You can team up with some establish pharma manufacturing company. The last and final step is to verify the license requirements. Establish your brand in the market. Once the company is launched, it is time to promote the brand by using every possible channel.

Manufacturing 67

Manufacturing Branding Pharma Companies Pharma Production 67

pharmaphorum

DECEMBER 8, 2022

The FDA has started its review of Pfizer’s respiratory syncytial virus (RSV) vaccine for older adults, fast-tracking the biologics license application (BLA) with a decision due in May 2023. The bulk of the market is, however, expected to be in older adults.

Vaccination 59

Vaccination Vaccine FDA Approval Pharma Companies 59

pharmaphorum

APRIL 22, 2021

Although the company has no agreements in place to acquire any companies, or license in any drugs, Centessa is interested in exploring such opportunities if they arise. Only time will tell whether de Rubertis’ bold claims lead to marketable drugs and only four of them are in the clinic.

Licensing 54

Licensing Licensing Pharma Companies Drugs 54

pharmaphorum

DECEMBER 28, 2022

M&A is an integral part of the lifecycle of pharma companies and a key strategy to future-proof larger players, driving R&D activities and innovation for a competitive product pipeline. But what steps can the smaller companies at the cutting edge take to make them acquisition-ready and maximise their value during this process?

Compliance 117

Compliance Regulation Manufacturing Licensing 117

pharmaphorum

FEBRUARY 13, 2022

If all goes to plan, Merck has the option to obtain up to a five-year exclusive license to use of BioAI in a specific disease domain, which would result in an undisclosed payment to the Israeli startup. “If successful, this could lead to a much-needed transformation in drug development speed, safety and cost,” said Ciechanover.

Drugs 98

Drugs In-Vivo In-Vitro Pharma Companies 98

Camargo

SEPTEMBER 23, 2020

The panelists brought diverse perspectives on the future of orphan drug development, how their companies evaluate new potential products and partnering opportunities, and how they are working to address challenges like clinical study design and patient recruitment. Marketing Manager. Content Marketing Associate. Taylor Anderson.

Business Development 136

Business Development Drugs Development Production 136

pharmaphorum

SEPTEMBER 18, 2020

But although it was dubbed a “dangerous game”, some companies came out on top… On 6th April 1999, two companies with similar science-based cultures and a shared vision of the pharmaceutical industry came together to form what’s now considered as one of the top ten pharma companies in the world: AstraZeneca.

Pharma Companies 116

Pharma Companies Sales Vaccine Vaccination 116

pharmaphorum

JUNE 4, 2021

At the moment, Xofigo is the only approved TAT on the market, but Bayer is also developing a pipeline of other candidates based on thorium-227 linked to antibodies or small-molecule drugs. The technology behind the drug was licensed from Weill Cornell Medicine and Johns Hopkins University in the US.

Antibody 63

Antibody Licensing Licensing Protein 63